MedPath

Effect of calcitonin in frozen shoulder treatment

Phase 3
Recruiting
Conditions
Frozen shoulder.
Adhesive capsulitis of unspecified shoulder
M75.00
Registration Number
IRCT20220523054971N1
Lead Sponsor
Islamic Azad University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
64
Inclusion Criteria

Patients with a clinical diagnosis of frozen shoulder
Patients symptoms including limitation in all active and passive movements of the shoulder joint in all directions
Patients with relatively severe pain
Patients with reduction in the range of motion of the shoulder
Definite confirmation of the diagnosis with the help of MRI of the shoulder joint

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Pain changes with visual analogue scale(VAS). Timepoint: 6 weeks after receiving calcitonin nasal spray. Method of measurement: Visual analogue scale.;Changes in the range of motion with the angle scale in degrees. Timepoint: 6 weeks after receiving calcitonin nasal spray. Method of measurement: Degrees of angle.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath